NGM282 Significantly Reduces Hepatic Steatosis Independent of Baseline Patient Characteristics and Highly Correlates with Markers of FGFR4 Target Engagement: Results from a Phase 2 Trial in Biopsy-Confirmed NASH Patients

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Loomba, R; Abdelmalek, MF; Trotter, JF; Paredes, AH; Jaros, M; Ling, L; Rossi, SJ; DePaoli, AM; Rinella, ME; Harrison, SA

Published Date

  • October 1, 2017

Published In

Volume / Issue

  • 66 /

Start / End Page

  • 1152A - 1152A

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-3350

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Conference Location

  • Washington, DC

Conference Start Date

  • October 20, 2017

Conference End Date

  • October 24, 2017